AbbVie struck a big deal to enter the hot PD-1xVEGF bispecific space. | In this week's Asia news recap, AbbVie struck a big ...

New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...

In 2023, Teva made a pledge to bolster its innovative medicines portfolio without leaving behind its century-long legacy as a ...

The FDA has told the makers of six flu vaccines that they need to add a notification to the label of their shots, warning of ...

The regulator’s Office of Prescription Drug Promotion (OPDP) has already sent out two letters alleging “false or misleading” ...

Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...

This time, Tecvayli excelled as a solo agent, reducing the risk of disease progression or death by 71% over standard of care ...

Hologic has drafted professional basketball player Erica Wheeler to raise awareness of cervical cancer screening, putting the ...

The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...

In fact, the price of such vouchers has been climbing steadily in recent months, according to public disclosures surrounding ...

To promote its newly launched nonhormonal menopause drug, Bayer is linking Lynkuet with a familiar face. The Big Pharma has recruited Gabrielle Union-Wade to serve as a celebrity endorser for the ...

The first two days of the J.P. Morgan Healthcare Conference are in the books, and attendees are now pushing through to finish ...